StockDrifts LogoStockDrifts

Guangdong Health Bio 086220

Company
광동헬스바이오Guangdong Health Bio
Insiders
0
Buys
0
Total Value
—
Avg Return
—
Last Filing
2026-07-13

Guangdong Health Bio (086220) has 0 disclosed insider purchases and 0 disclosed disposals on record, filed by 0 distinct insiders. The earliest filing StockDrifts holds for Guangdong Health Bio is dated 2024-08-19; the most recent is 2026-07-13.

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2026-07-13BUY장외매수
비엘팜텍
BL Pharmtech
-727.3K₩890-24.9%₩1.0B ($727K)
2025-11-05BUY제3자배정유상증자
광동제약
Kwangdong Pharmaceutical
-2.1M₩1,400+6.9%₩3.0B ($2.1M)
2024-08-19BUY장외매수
비엘팜텍
BL Pharmtech
-1.0M---

Frequently asked questions

Who has been buying Guangdong Health Bio stock?
0 distinct insiders have filed 0 disclosed insider purchases in Guangdong Health Bio (086220), most recently on 2026-07-13. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Guangdong Health Bio have?
Guangdong Health Bio has 0 buy-side and 0 sell-side disclosures on record, spanning 2024-08-19 to 2026-07-13.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

More on this data

Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.